Vilon — Khavinson dipeptide bioregulator — immune / thymic
Vilon (Lys-Glu) is the simplest Khavinson bioregulator — a dipeptide that acts as a broad immunomodulator. Activates HLA-DR and CD54 expression in thymic cells, normalizes lymphocyte blast transformation, activates T-helper cells via apoptosis inhibition, and reactivates chromatin in aged lymphocytes. Used in diverse clinical contexts: thyroid disease, diabetes, radiation protection.
Overview
This page is part of Hormonaly's evidence-graded compound library. All clinical claims are linked to peer-reviewed sources via our dual-layer citation verification pipeline.
Compound Class
Khavinson dipeptide bioregulator — immune / thymic
Mechanism of Action
Vilon (Lys-Glu) is the simplest Khavinson bioregulator — a dipeptide that acts as a broad immunomodulator. Activates HLA-DR and CD54 expression in thymic cells, normalizes lymphocyte blast transformation, activates T-helper cells via apoptosis inhibition, and reactivates chromatin in aged lymphocytes. Used in diverse clinical contexts: thyroid disease, diabetes, radiation protection.
Regulatory Status
Not FDA approved. Available as research peptide. Used in Russia as part of Khavinson bioregulator protocols.
Evidence Level
Moderate — multiple published clinical studies covering several indications; long-term cohort data (n=266, 6–8 years). Primarily Khavinson group.